Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Drug-coated Balloon-only Angioplasty
Author(s): Upul Wickramarachchi , Simon Eccleshall Added: 3 years ago
Percutaneous coronary interventional techniques and devices have evolved enormously since Gruntzig performed his first coronary angioplasty in 1977. 1 It is now the norm to treat patients with both acute coronary syndrome and stable coronary artery disease with drug-eluting stents. We intend to review the evidence and discuss potential benefits of drug-coated balloon-only angioplasty. These… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
EuroPCR 2021: Drug-coated Balloons vs Drug Eluting Stents
Author(s): Upul Wickramarachchi Added: 2 years ago
In this video, Dr Upul Wickramarachchi (Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK) discusses the clinical outcomes of drug-coated balloon angioplasty treated patients versus drug-eluting stent treated patients for de novo coronary artery disease in all vessel sizes. Questions 1. What question does this study aim to address? 2. What was the design, patient cohort… View more

Intervention
Drug-coated Balloons - History and Peripheral Vascular Opportunities
Author(s): Bruno Scheller , Bodo Cremers , Stephanie Schmitmeier , et al Added: 3 years ago
One of the most innovative fields of modern medical research is the percutaneous transluminal treatment of vascular disease. Coronary angioplasty was clinically introduced by Andreas Grüntzig in 1977.1 In the coronary field the most important improvement in angioplasty has been achieved with the introduction of stents. A significant proportion of complex modern coronary interventional techniques… View more

Intervention
EuroPCR 22: EASTBOURNE Registry indicates Satefy of Sirolimus-Coated Balloon
Author(s): Bernardo Cortese Added: 1 year ago
Dr Bernardo Cortese (La Fondazione Ricerca e Innovazione Cardiovascolare, IT) discusses the findings from the EASTBOURNE Registry, a study that investigated the sirolimus-coated balloon in an all-comer population. Findings are positive in regard to the device's safety and efficacy profile, with no safety signals for bleeding and the primary endpoint of target lesion revascularization (TLR), was… View more

Intervention
Drug-coated Balloons for Small Coronary Vessel Interventions: A Literature Review
Author(s): Raban Jeger , Thomas Nestelberger Added: 3 years ago
Coronary artery disease (CAD) remains a major cause of morbidity and mortality despite major improvements in primary and secondary prevention strategies. Percutaneous coronary intervention (PCI) or surgical revascularisation may be indicated in many patients with acute or stable CAD.1 Since the first coronary intervention using catheter mounted balloons, percutaneous treatment of CAD has evolved… View more

Intervention
DEB versus DES in Small Artery PCI: Meta-analysis
Author(s): Greg Murphy , Ailish Naughton , Rory Durand , et al Added: 12 months ago

MI/ACS

Intervention
Job title: Chairman of the Department of Vascular Surgery
Dr Sean Lyden is the Chairman of the Department of Vascular Surgery at Cleveland Clinic’s Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute. Dr Lyden earned his medical degree from the University of Cincinnati College of Medicine following an undergraduate degree from the University of Notre Dame. He served a residency in general surgery at the University of Tennessee Health… View more
Author(s): Gary M Ansel , Peter A Schneider Added: 3 years ago
Clinical Infrapopliteal Disease Critical limb ischaemia (CLI) typically presents as rest pain, tissue ulceration or frank tissue loss with gangrene, often accompanied by infection. Occasionally a patient may also present with claudication that is so severe that the patient is restricted to a few feet of ambulation. These patients sometimes have early rest pain on further questioning. Diabetics… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
Hybrid Strategy Using DES and DCB in Diffuse CAD
Author(s): Alfonso Ielasi Added: 9 months ago
This video features Dr Alfonso Ielasi (IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, IT) presenting a dynamic poster focused on the 2-Year Follow-up of a Hybrid Strategy for Diffuse Coronary Artery Disease (CAD).He highlights the challenging nature of de novo diffuse coronary artery disease (CAD) in interventional cardiology, where limited treatment options exist beyond stent implantation.To… View more

Intervention